部份中文替考拉宁处方资料（仅供参考）
英文名：Teicoplanin
商品名：Teicoplanin for I.V. Infusion
中文名：替考拉宁注射用
生产商：明治药品
药品简介
Teicoplanin (替考拉宁，テイコプラニン点滴静注用) 是一种预防用的抗生素。用于治疗各种严重的革兰阳性菌感染，包括不能用青霉素类和头孢菌素类其他抗生素者。本品可用于不能用青霉素类及头孢菌素类抗生素治疗或用上述抗生素治疗失败的严生葡萄球菌感染，或对其他抗生素耐药的葡萄球菌感染。
テイコプラニン点滴静注用200mg「明治」/テイコプラニン点滴静注用400mg「明治」 
药物分类名称
糖肽类抗生素制剂
批准日期：2013年6月
欧文商標名
TEICOPLANIN for I.V. Infusion 200mg 「MEIJI」
TEICOPLANIN for I.V. Infusion 400mg 「MEIJI」
性　状
替考拉宁是白色至浅黄白色粉末。
该产品易溶于水，微溶于N，N-二甲基甲酰胺，几乎不溶于乙腈，甲醇，乙醇（95），丙酮，乙酸（100）或乙醚。
一般名
テイコプラニン　Teicoplanin
化学名（本質）
テイコプラニンA2－1、テイコプラニンA2－2、テイコプラニンA2－3、テイコプラニンA2－4、テイコプラニンA2－5及びテイコプラニンA3－1等の混合物
分子式
C72～89H68～99Cl2N8～9O28～33
分子量
1564.25～1893.68
構造式
处理注意事项
稳定性测试
使用包装产品加速试验（40°C，相对湿度75％，6个月），200毫克替考拉宁用于静脉输注“明治”和替考拉宁IV用于静脉输注400毫克“明治”，正常市场流通3年 据推测，它是稳定的。
批准条件
有必要彻底调查该药物使用该药物后的耐受性和万古霉素耐药细菌的外观状态，并向医务人员提供信息。
适应症
<适应性真菌种类>
耐甲氧西林金黄色葡萄球菌（MRSA）对该药物敏感
<适应症>
继发感染如败血症，深部皮肤感染，慢性脓皮病，创伤/烧伤和手术伤口，肺炎继发感染，脓胸，慢性呼吸道病变
用法与用量
通常，成人在第一天被分为两组400mg（滴度）或800mg（效力）作为替考拉宁，然后静脉内施用每天一次超过30分钟200mg（滴度）或400mg（效力）到。 对于败血症，第一天800mg（滴度）被分成两份，并且每天一次400mg（效力）在30分钟内静脉内给药。
通常婴儿，婴儿或儿童每12小时接受10 mg（滴度）/kg三次替考拉宁，然后6至10mg（效力）/kg（10 mg（效力）/kg用于严重感染，如败血症/每24小时超过30分钟或更长时间。 对于新生儿（包括低出生体重婴儿），静脉滴注作为替考拉宁首次仅给予16mg（效力）/kg，然后每24小时30分钟给予8mg（滴度）/ kg。
另外，应该根据年龄，体重和症状来增加或减少。
包装
静脉输注
200毫克“明治”
10个小瓶，在1个小瓶中含有200mg（效力）
400毫克“明治”
10个小瓶，在1个小瓶中含有400mg（效力）
制造供应商
制造供应商
明治制药有限公司
注：以上中文处方资料不够完整，使用者以原处方资料为准。
完整资料附件：
http://www.info.pmda.go.jp/go/pack/6119401D1159_1_01/
-------------------------------------------------------
TEICOPLANIN for I.V. Infusion（Teicoplanin）
TEICOPLANIN for I.V. Infusion 400mg "MEIJI"（テイコプラニン点滴静注用400mg「明治」）
Brand name : TEICOPLANIN for I.V. Infusion 400mg "MEIJI"
　Active ingredient: Teicoplanin
　Dosage form: Injection
　Print on wrapping:
Effects of this medicine
This medicine is a glycopeptide antibiotic which inhibits cell wall synthesis of bacteria and shows an antibacterial effect.
It is usually used to treat sepsis, deep-seated skin infection, chronic pyoderma, secondary infection in injury/burn or surgical wound, pneumonia, pyothorax and secondary infection in chronic respiratory lesion.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have: hearing difficulty, renal disorder or liver disorder.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
•In general, for adults, this medicine is administered by intravenous infusion over a period of 30 minutes or longer twice a day on Day 1. Then administered once a day. For infants and children, administered by intravenous infusion over a period of 30 minutes or longer three times at an intervals of 12 hours. Then administered at an intervals of 24 hours. For neonates (including low birth-weight baby), administered by intravenous infusion over a period of 30 minutes or longer at an intervals of 24 hours.
•The treatment period with this medicine is determined based on your symptoms.
Precautions while taking this medicine
•Keep all appointments/laboratory test schedules if periodic blood test is needed.
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include fever and rash. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
•bronchospasm, angioedema, respiratory distress [shock, anaphylactoid symptoms]
•dizziness, tinnitus, decreased hearing [8th cranial nerve disorder]
•high fever, erosion in lips/genitalia, bloodshot eyes [toxic epidermal necrolysis, muco-cutaneo-ocular syndrome, erythroderma (exfoliative dermatitis)]
•high fever, sore throat, gum bleeding [agranulocytosis, leucopenia, thrombocytopenia]
•decreased urine output, edema, thirst [acute renal failure]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Meiji Seika Pharma Co., Ltd.Injection
Published: 2/2015
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.